WS Data Solutions
Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Immunovant, Inc. Common Stock (IMVT)
Biological Products, (no Disgnostic Substances)
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
320 WEST 37TH STREET
NEW YORK, NY
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/21/2019
Market Cap
4,398,313,713
Shares Outstanding
144,660,000
Weighted SO
144,661,930
Total Employees
N/A
Upcoming Earnings
08/08/2024
Similar Tickers
Beta
0.7130
Last Div
0.0000
Range
19.34-45.58
Chg
-0.8301
Avg Vol
1150090
Mkt Cap
4398313713
Exch
NASDAQ
Country
US
Phone
917 580 3099
DCF Diff
25.6803
DCF
4.5997
Div Yield
0.0000
P/S
2932.2091
EV Multiple
-13.3119
P/FV
8.0598
Div Yield %
0.0000
P/E
-16.1067
PEG
1.6201
Payout
0.0000
Current Ratio
13.0847
Quick Ratio
13.0847
Cash Ratio
12.4396
DSO
588.1367
DIO
0.0000
Op Cycle
588.1367
DPO
7309.9365
CCC
-6721.7998
Gross Margin
0.6327
Op Margin
-189.9293
Pretax Margin
-181.2627
Net Margin
-181.6993
Eff Tax Rate
-0.0024
ROA
-0.4622
ROE
-0.5207
ROCE
-0.5231
NI/EBT
1.0024
EBT/EBIT
0.9544
EBIT/Rev
-189.9293
Debt Ratio
0.0001
D/E
0.0001
LT Debt/Cap
0.0000
Total Debt/Cap
0.0001
Int Coverage
0.0000
CF/Debt
-3522.5507
Equity Multi
1.0827
Rec Turnover
0.6206
Pay Turnover
0.0499
Inv Turnover
0.0000
FA Turnover
2.3772
Asset Turnover
0.0025
OCF/Share
-1.6638
FCF/Share
-1.6672
Cash/Share
3.8334
OCF/Sales
-162.0373
FCF/OCF
1.0020
CF Coverage
-3522.5507
ST Coverage
-3522.5507
CapEx Coverage
-489.0463
Div&CapEx Cov
-489.0463
P/BV
8.0598
P/B
8.0598
P/S
2932.2091
P/E
-16.1067
P/FCF
-18.0590
P/OCF
-18.0611
P/CF
-18.0611
PEG
1.6201
P/S
2932.2091
EV Multiple
-13.3119
P/FV
8.0598
DPS
0.0000